Strateos nabs $56M for SmartLab Platform

By The Science Advisory Board staff writers

Strateos announced it closed on $56 million in financing to continue to drive innovations on its SmartLab Platform.

Strateos develops remote-access laboratories and lab control software for life science research. Its SmartLab Platform integrates data generation and artificial intelligence automation to accelerate pharmaceutical and synthetic biology research and development.

The financing was led by DCVC and Lux Capital with participation from new investors, including Eli Lilly, Ally Bridge Group, Black Diamond Ventures, Mack & Co., and Castor Ventures, Strateos said.

Copyright © 2021

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?